SHH · 688656.SS · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
HOB Biotech Group Corp.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 56.8% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
HOB Biotech Group Corp.,Ltd’s forward annual dividend is CN¥0.20 per share, paid annual. The forward yield is 0.21% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
HOB Biotech Group Corp.,Ltd’s next earnings report is currently expected on Oct 30, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow HOB Biotech Group Corp.,Ltd’s reporting calendar.
THE COMPANY BEHIND THE TICKER
HOB Biotech Group Corp.,Ltd. is an international in vitro diagnostics firm, active in both China and various global markets. It supplies advanced diagnostic assays, such as line immune, enzyme-linked immunosorbent, and chemiluminescent paramagnetic microparticle immunoassays, to laboratories and hospitals. This endeavor aims to improve the treatment and care for patients afflicted with allergies and autoimmune diseases. The company was established in 2009 and is headquartered in Suzhou, China.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:36 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥85.87+CN¥3.47 (+4.21%)
Shanghai MicroPort Endovascular MedTech Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 25.97% below the high.
CN¥18.01-CN¥0.12 (-0.66%)
Sinocare Inc.’s quoted price sits in the upper half of its reported 52-week range, 11.37% below the high.
CN¥20.22-CN¥0.13 (-0.64%)
Dian Diagnostics Group Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 39.28% below the high.
CN¥21.60+CN¥0.46 (+2.18%)
SonoScape Medical Corp.’s quoted price sits in the lower half of its reported 52-week range, 28.57% below the high.
CN¥12.44-CN¥0.07 (-0.56%)
Shinva Medical Instrument Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 27.97% below the high.
CN¥15.98-CN¥0.10 (-0.62%)
Guangzhou Wondfo Biotech Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 39.22% below the high.
CN¥10.10-CN¥0.16 (-1.56%)
Beijing Wandong Medical Technology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 44.63% below the high.
CN¥9.16-CN¥0.57 (-5.86%)
Shanghai Runda Medical Technology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 55.9% below the high.
